FTC to Ramp Up Enforcement Against Illegal Rebate Schemes, Bribes to Prescription Drug Middlemen
In a new enforcement policy statement, the Federal Trade Commission announced that it will step up enforcement actions against bribes and rebate schemes that block patients’ access to competing lower-cost drugs.
🔒 Members Only · Compliance & Enforcement BriefYou’ve reached the member portion of this brief.Members read the full analysis and the source documents in every Brief, six days a week.